The Top 100 U.S. In-Vitro Diagnostics Companies

Publisher Name :
Date: 13-Sep-2016
No. of pages: 210

Did you know?


  • Nova Biomedical is the largest privately owned in-vitro diagnostic company in the United States.

  • As of December 31, 2015, Exact Sciences Corporation had 677 full-time employees.

  • Sandy Athenson is Vice President & General Manager, Transfusion Diagnostics at Immucor, Inc..

  • In August, 2016, Alere Inc. received FDA Clearance for its Alere™ i RSV test, the first rapid molecular test that can be used at the point-of-care to detect RSV infection in 13 minutes or less.

  • As of December 31, 2015, more than 19,000 physicians in over 70 countries had ordered OncotypeDX gene expression tests from Genomic Health, Inc. which have been used to guide treatment decisions for more than 600,000 cancer patients worldwide.

  • In January, 2016, Banyan Biomarkers, Inc. and Royal Philips announced that they had entered into a multi-year joint development agreement to develop and commercialise a new handheld blood test to detect and evaluate mild traumatic brain injury at the point-of-care.

  • For the year ended December 31, 2015, Cepheid reported revenue of $538.6 million.


These are just a tiny sample of the 1,000's of facts to be found in ‘The Top 100 U.S. In-Vitro Diagnostics Companies'.

This unique and comprehensive report profiles the top 100 U.S. manufacturers of in-vitro diagnostics. These global leaders are continually developing new and innovative products to add to their already comprehensive portfolios. They are located right across the United States and have highly effective worldwidecommercial networks.

Profile information for each company in ‘The Top 100 U.S. In-Vitro Diagnostics Companies'typically includes:


  • Company Contact Information - Address, Telephone and Fax Numbers, Email and Website Addresses

  • Key Company Decision Makers - From CEO and Main Board, to Key Senior Managers

  • Specialised fields such as Company Description, Ownership, Products, Clinical Specialties/Diseases, Diagnostic Disciplines, Revenue, Year Established and Number of Employees.


Report Target Market:

1) IVD Manufacturers


  • Usage: competitive/financial analysis and strategic partner/alliance identification


2) IVD Suppliers


  • ‘The Top 100 U.S. In-Vitro Diagnostics Companies' is perfect for suppliers of goods and services such as components and sub-assemblies and development, design and manufacturing services who wish to identify top potential customers.


3) IVD Distributors


  • The report is very useful to IVD distributors to identifythe leading U.S. in-vitro diagnostics companies withthe best products.


Note: Most people will be aware of some of the major U.S. in-vitro diagnostics companies such as ACON Laboratories, Inc., Abaxis, Inc., Myriad Genetics, Inc., Ortho Clinical Diagnostics and Quidel Corporationbut this major new report looks at all 100 of the top companies - companies like - GenMark Diagnostics, Inc. - GenMark Diagnostics, Inc. (NASDAQ: GNMK) is a leading provider of automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. The Company's XT-8® system is designed to support a broad range of molecular diagnostic tests with a compact, easy-to-use workstation and self-contained, disposable test cartridges. As of December 31, 2015, GenMark had an installed base of 633 XT-8® systems, or placements, with their customers. In June, 2016, the Company achieved the CE Mark for its ePlex sample-to-answer multiplex molecular diagnostics System and ePlex Respiratory Pathogen (RP) Panel. GenMark is headquartered in Carlsbad, California, United States, had annual revenue of $39.4 million in 2015 and has 233 employees. The Company is led by Hany Massarany, President And Chief Executive Officer.

Report data field structure is as follows:


  • Company Name

  • Address

  • Telephone

  • Fax

  • Email

  • Website

  • Year Established

  • Number of Employees

  • Key Executives

  • Company Description

  • Products

  • Clinical Specialties/Diseases

  • Diagnostic Disciplines

  • Revenue ($U.S. million)

  • Location Status

  • Ownership

  • Stock Exchange/Ticker Symbol

  • Parent Company

The Top 100 U.S. In-Vitro Diagnostics Companies

Table of Contents

N/A

  • Global IVD Products Sales Market Report 2017
    Published: 22-Nov-2017        Price: US 4000 Onwards        Pages: 118
    In this report, the global IVD Products market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of IVD Products for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan - S......
  • Global Rapid Medical Diagnostic Kits Market Research Report 2017
    Published: 21-Nov-2017        Price: US 2900 Onwards        Pages: 124
    In this report, the global Rapid Medical Diagnostic Kits market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Rapid Medical Diagnostic Kits in these regions, from 2012 to 2022 (forecast), covering - North America - Europe......
  • Global In-Vitro Diagnostics (IVD) Market Size, Status and Forecast 2022
    Published: 17-Nov-2017        Price: US 3300 Onwards        Pages: 100
    This report studies the global In-Vitro Diagnostics (IVD) market, analyzes and researches the In-Vitro Diagnostics (IVD) development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Roche - Siemens - Danaher - Abbott - BD - Alere - SYSMEX - BioMerieux - J&J - BIO-RAD - Hologic - KHB Market segment by Re......
  • Therapeutic Drug Monitoring (TDM) Market 2021: US, Europe, Japan--Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 8500 Onwards        Pages: 0
    Complete report $8,500. DataPack (test volumes, sales forecasts, supplier shares) $5,500.This new 313-page report from VPGMarketResearch.com contains 83 tables and provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and m......
  • France Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Pr......
  • Germany Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 249-page report from VPGMarketResearch.com provides a comprehensive analysis of the German therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Pr......
  • Italy Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the Italian therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/P......
  • Japan Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2750 Onwards        Pages: 0
    This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the Japanese therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/......
  • Spain Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation ReviewReview
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 249-page report from VPGMarketResearch.com provides a comprehensive analysis of the Spanish therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/P......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs